These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30064986)

  • 1. Periendoscopic management of direct oral anticoagulants: a prospective cohort study.
    Radaelli F; Fuccio L; Paggi S; Hassan C; Repici A; Rondonotti E; Semeraro R; Di Leo M; Anderloni A; Amato A; Trovato C; Bravi I; Buda A; de Bellis M; D'Angelo V; Segato S; Tarantino O; Musso A; Fasoli R; Frazzoni L; Liverani E; Fabbri C; Di Giulio E; Esposito G; Pigò F; Iannone A; Dentali F;
    Gut; 2019 Jun; 68(6):969-976. PubMed ID: 30064986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic endoscopy-related GI bleeding and thromboembolic events in patients using warfarin or direct oral anticoagulants: results from a large nationwide database analysis.
    Nagata N; Yasunaga H; Matsui H; Fushimi K; Watanabe K; Akiyama J; Uemura N; Niikura R
    Gut; 2018 Oct; 67(10):1805-1812. PubMed ID: 28874418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
    Sengupta N; Feuerstein JD; Patwardhan VR; Tapper EB; Ketwaroo GA; Thaker AM; Leffler DA
    Am J Gastroenterol; 2015 Feb; 110(2):328-35. PubMed ID: 25512338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists.
    Rodríguez de Santiago E; Sánchez Aldehuelo R; Riu Pons F; Rodríguez Escaja C; Fernández-Esparrach G; Cañete-Ruiz Á; Ferre Aracil C; Pérez-Corte D; Ríos León R; Marcos-Prieto HM; Delgado-Guillena PG; García-Rodríguez A; Guarner-Argente C; Muriel A; de la Fuente-Briongos E; García García de Paredes A; Parejo-Carbonell S; Téllez L; Senosiaín-Lalastra C; Burgos-Santamaría D; Aicart-Ramos M; Mateos Muñoz B; Peñas-García B; Pagano G; Casals Urquiza G; Urpi Ferreruela M; Ángel de Jorge-Turrión M; Barreiro-Alonso E; Fraile-López M; Gómez-Outomuro A; Altamirano MI; Núñez Esteban M; Ruiz-Andreu M; Arribas-Anta J; de Frutos D; Herreros-de-Tejada A; Arias-Rivera ML; Roldán-Fernández M; Marcos Martín ÁF; Zamora J; Vázquez-Sequeiros E; Albillos A;
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e380-e397. PubMed ID: 33279783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprocedural Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy.
    Hansen-Barkun C; Martel M; Douketis J; Abraham NS; Liederman Z; Kaplovitch E; Schulman S; Spyropoulos AC; Majid A; Barkun AN
    Am J Gastroenterol; 2023 May; 118(5):812-819. PubMed ID: 36434811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes.
    Shaw JR; Douketis J; Le Gal G; Carrier M
    J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
    Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
    BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events associated with anticoagulation therapy in the periendoscopic period.
    Gerson LB; Michaels L; Ullah N; Gage B; Williams L
    Gastrointest Endosc; 2010 Jun; 71(7):1211-1217.e2. PubMed ID: 20598248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
    Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S;
    Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.
    Veitch AM; Vanbiervliet G; Gershlick AH; Boustiere C; Baglin TP; Smith LA; Radaelli F; Knight E; Gralnek IM; Hassan C; Dumonceau JM
    Gut; 2016 Mar; 65(3):374-89. PubMed ID: 26873868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebleeding vs Thromboembolism After Hospitalization for Gastrointestinal Bleeding in Patients on Direct Oral Anticoagulants.
    Sengupta N; Marshall AL; Jones BA; Ham S; Tapper EB
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1893-1900.e2. PubMed ID: 29775794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter study on hemorrhagic risk of heparin bridging therapy for periendoscopic thromboprophylaxis.
    Matsumoto M; Mabe K; Tsuda M; Ono M; Omori S; Takahashi M; Yoshida T; Ono S; Nakagawa M; Nakagawa S; Shimizu Y; Kudo T; Sakamoto N; Kato M
    BMC Gastroenterol; 2015 Jul; 15():89. PubMed ID: 26215103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombotic therapy and digestive endoscopy].
    Cyrany J; Malý R; Rejchrt S; Tachecí I
    Vnitr Lek; 2022; 68(8):538-542. PubMed ID: 36575073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulation and antiplatelet therapy, and gastrointestinal endoscopy].
    Székely H; Tulassay Z
    Orv Hetil; 2009 Mar; 150(12):541-8. PubMed ID: 19275971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal endoscopy in patients receiving novel direct oral anticoagulants: results from the prospective Dresden NOAC registry.
    Heublein V; Pannach S; Daschkow K; Tittl L; Beyer-Westendorf J
    J Gastroenterol; 2018 Feb; 53(2):236-246. PubMed ID: 28493007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period.
    Abraham NS; Barkun AN; Sauer BG; Douketis J; Laine L; Noseworthy PA; Telford JJ; Leontiadis GI
    Am J Gastroenterol; 2022 Apr; 117(4):542-558. PubMed ID: 35297395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periprocedural heparin bridging in patients receiving oral anticoagulation: a systematic review and meta-analysis.
    Yong JW; Yang LX; Ohene BE; Zhou YJ; Wang ZJ
    BMC Cardiovasc Disord; 2017 Dec; 17(1):295. PubMed ID: 29237411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry.
    Beyer-Westendorf J; Gelbricht V; Förster K; Ebertz F; Köhler C; Werth S; Kuhlisch E; Stange T; Thieme C; Daschkow K; Weiss N
    Eur Heart J; 2014 Jul; 35(28):1888-96. PubMed ID: 24394381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.